EUDA Announces 1-for-20 Reverse Stock Split to Boost Share Price, Likely for Nasdaq Compliance
Summary
EUDA Health Holdings announced a 1-for-20 reverse stock split of its ordinary shares, effective March 23, 2026, reducing outstanding shares from approximately 50.3 million to 2.5 million. This action is a common strategy for companies trading significantly below exchange minimum bid requirements, such as Nasdaq's $1.00 threshold, which EUDA's current share price of $0.4025 falls well short of. While the split mechanically increases the per-share price, it does not alter the company's market capitalization or fundamental value and is often perceived by investors as a signal of financial distress. Historically, reverse splits can be followed by further share price declines or additional dilutive financing, especially for companies that have recently engaged in capital raises as EUDA has. Traders will closely watch the stock's performance post-split and any future announcements regarding its financial health and compliance status.
At the time of this announcement, EUDA was trading at $0.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.8M. The 52-week trading range was $0.46 to $4.30. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.